In a healthcare system where cancer patients often wait days—or even weeks—for life-saving treatments due to administrative red tape, RISA Labs is stepping in with a powerful, AI-native solution designed to eliminate one of the most persistent bottlenecks in oncology: prior authorization delays. Today, the Palo Alto-based startup announced a $3.5 million seed round led […]<br /> The po [...]